LYPE.DE vs. XGEN.DE
LYPE.DE (Amundi MSCI World Health Care UCITS ETF EUR Acc) and XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both Health & Biotech Equities funds - LYPE.DE tracks the MSCI World Health Care while XGEN.DE tracks the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Both are passively managed. Over the past 3 years, LYPE.DE returned 2.46%/yr vs 1.39%/yr for XGEN.DE. A 0.67 correlation means they provide meaningful diversification when combined. Both charge a 0.30% expense ratio.
Performance
LYPE.DE vs. XGEN.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LYPE.DE achieves a -2.00% return, which is significantly lower than XGEN.DE's -1.40% return.
LYPE.DE
- 1D
- 2.79%
- 1M
- 3.48%
- YTD
- -2.00%
- 6M
- -1.61%
- 1Y
- 9.70%
- 3Y*
- 2.46%
- 5Y*
- 5.27%
- 10Y*
- 7.45%
XGEN.DE
- 1D
- 3.92%
- 1M
- 5.33%
- YTD
- -1.40%
- 6M
- -3.45%
- 1Y
- 22.88%
- 3Y*
- 1.39%
- 5Y*
- —
- 10Y*
- —
LYPE.DE vs. XGEN.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
LYPE.DE Amundi MSCI World Health Care UCITS ETF EUR Acc | -2.00% | 2.17% | 7.03% | -0.27% | -0.51% |
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.40% | 7.38% | 2.95% | -5.84% | -9.98% |
Correlation
The correlation between LYPE.DE and XGEN.DE is 0.72, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.72 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.67 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022 | 0.67 |
The correlation between LYPE.DE and XGEN.DE has been stable across timeframes, ranging from 0.67 to 0.72 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LYPE.DE vs. XGEN.DE — Risk / Return Rank
LYPE.DE
XGEN.DE
LYPE.DE vs. XGEN.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LYPE.DE | XGEN.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.54 | ||
| Sortino ratioReturn per unit of downside risk | -0.72 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.21 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 0.93 | 1.49 | -0.56 |
| Martin ratioReturn relative to average drawdown | 2.27 | 3.61 | -1.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LYPE.DE | XGEN.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.68 | 1.23 | -0.54 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.39 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.51 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.76 | -0.11 | +0.87 |
Drawdowns
LYPE.DE vs. XGEN.DE - Drawdown Comparison
The maximum LYPE.DE drawdown since its inception was -25.95%, smaller than the maximum XGEN.DE drawdown of -37.58%. Use the drawdown chart below to compare losses from any high point for LYPE.DE and XGEN.DE.
Loading charts...
Drawdown Indicators
| LYPE.DE | XGEN.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.95% | -37.58% | +11.63% |
Max Drawdown (1Y)Largest decline over 1 year | -10.21% | -14.99% | +4.78% |
Max Drawdown (3Y)Largest decline over 3 years | -21.30% | -28.21% | +6.91% |
Max Drawdown (5Y)Largest decline over 5 years | -21.30% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -25.95% | — | — |
Current DrawdownCurrent decline from peak | -8.75% | -14.86% | +6.11% |
Average DrawdownAverage peak-to-trough decline | -5.06% | -19.44% | +14.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.18% | 6.19% | -2.01% |
Volatility
LYPE.DE vs. XGEN.DE - Volatility Comparison
The current volatility for Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE) is 4.96%, while Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) has a volatility of 6.48%. This indicates that LYPE.DE experiences smaller price fluctuations and is considered to be less risky than XGEN.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LYPE.DE | XGEN.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.96% | 6.48% | -1.52% |
Volatility (6M)Calculated over the trailing 6-month period | 9.76% | 13.73% | -3.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.82% | 18.19% | -4.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.41% | 18.66% | -5.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.64% | 18.66% | -4.02% |
LYPE.DE vs. XGEN.DE - Expense Ratio Comparison
Both LYPE.DE and XGEN.DE have an expense ratio of 0.30%.
Dividends
LYPE.DE vs. XGEN.DE - Dividend Comparison
Neither LYPE.DE nor XGEN.DE has paid dividends to shareholders.
Frequently Asked Questions
LYPE.DE and XGEN.DE have a correlation of 0.72, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.30% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
LYPE.DE and XGEN.DE have the same expense ratio: 0.30% per year.
LYPE.DE tracks MSCI World Health Care, while XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. They also come from different issuers: Amundi and Xtrackers.
Find the right allocation for LYPE.DE and XGEN.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer